Patented, bioactive menstrual care, solving the unmet vaginal health needs of 1 in 3 women globally.

Every month, millions of women use a tampon for up to 8 hours — a direct, sustained point of contact with one of the body's most absorbent environments. Menstruation creates a recurring biological window where hormonal shifts leave the vaginal microbiome temporarily vulnerable. Until now, no one has treated that window as a healthcare opportunity. We are building clinically validated tampons that deliver microbiome-supportive bioactives locally — unlike traditional passive tampons that offer no health benefit, probiotic supplements with limited clinical evidence, or antibiotics that temporarily treat symptoms while driving recurrence. We are currently raising a SEIS/EIS qualifying pre-seed equity round and welcome interest from aligned early-stage investors.